21 unchanged sentences
Other Information.
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
+Added: Not Applicable.
THE COOPER COMPANIES, INC.
34 unchanged sentences
Three Years Ended October 31, 2021
−Removed: (In millions)
+Added: (In millions) Balance
+Added: of Year Additions
+Added: Expenses (Deductions)
Allowance for doubtful accounts:
3 unchanged sentences
(1) Consists of additions representing allowances and recoveries, less deductions representing receivables written off as uncollectible.
−Removed: (In millions)
−Removed: Reductions/ Charges (2)
+Added: (In millions) Balance
+Added: of Year Additions Reductions/ Charges Balance
Deferred income tax valuation allowance:
2 unchanged sentences
Year Ended October 31, 2019 39.1 3.9 ( 1.5 ) 41.5
−Removed: Fiscal year 2018 reductions includes $ 16.5 million of valuation allowance from prior years as a result of the sale of investment in research and development credits.
THE COOPER COMPANIES, INC.
1 unchanged sentence
EXHIBIT INDEX
−Removed: Exhibit Number
−Removed: Description of Document
+Added: Exhibit Number Description of Document
3.1 Second Restated Certificate of Incorporation filed with the Delaware Secretary of State, incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K dated January 13, 2006
16 unchanged sentences
10.7# Form of Non-Qualified Stock Option Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit 10.32 of the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2007
−Removed: Form of UK Tax Approved Stock Option Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit 10.33 of the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2007
10.8# Form of Deferred Stock Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit 10.34 of the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2007
6 unchanged sentences
AND SUBSIDIARIES
−Removed: Exhibit Number
−Removed: Description of Document
+Added: Exhibit Number Description of Document
Amendment No.
5 unchanged sentences
10.19 Amendment No.
−Removed: 1 and Joinder, dated as of October 30, 2020, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrative agent
+Added: 1 and Joinder, dated as of October 30, 2020, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrat ive agent, incorporated by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2020
+Added: 10.20 Loan Agreement, dated as of November 2, 2021, among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent , incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated November 5 , 202 1
10.21# The Cooper Companies, Inc.
−Removed: 2020 Incentive Payment Plan, incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed December 16, 2019
−Removed: Transition and Retirement Agreement entered into by and between The Cooper Companies, Inc.
−Removed: and Randal L.
−Removed: Golden as of February 15, 2020, incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on March 6, 2020
−Removed: Transition and Retirement Agreement, by and between The Cooper Companies, Inc.
−Removed: and Robert D.
−Removed: Auerbach M.D., effective as of July 8, 2020, incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q dated September 4, 2020
+Added: 202 1 Incentive Payment Plan, incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed February 2 , 20 21
+Added: 10.22 Agreement and Plan of Merger, dated as of November 6, 2021, by and among T he Cooper Compan ies, I nc.
+Added: , CooperSurgical, Inc., Bruin Merger Sub, LLC, GI Generate Parent LLC, and GI Partners Acquisitions LLC., incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated November 10, 2021
+Added: 21 Subsidiaries
23 Consent of Independent Registered Public Accounting Firm
7 unchanged sentences
AND SUBSIDIARIES
−Removed: Exhibit Number
−Removed: Description of Document
+Added: Exhibit Number Description of Document
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
−Removed: The agreement received confidential treatment from the Securities and Exchange Commission with respect to certain portions of this exhibit.
+Added: (a) The agreement received confidential treatment from the Securities and Exchange Commission with respect to certain portions of this exhibit.
Omitted portions have been filed separately with the Commission.
14 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.
+Added: Signature Capacity Date
/s/ ALBERT G.
−Removed: President, Chief Executive Officer and Director (Principal Executive Officer)
−Removed: December 11, 2020
−Removed: THOMAS BENDER
−Removed: Chairman of the Board
−Removed: December 11, 2020
−Removed: Thomas Bender)
−Removed: RUBENSTEIN, M.D.
−Removed: Vice Chairman of the Board and Lead Director
−Removed: December 11, 2020
−Removed: Executive Vice President, Chief Financial Officer & Treasurer
−Removed: December 11, 2020
−Removed: (Principal Financial Officer)
−Removed: /s/ AGOSTINO RICUPATI
−Removed: Chief Accounting Officer & Senior Vice President, Finance & Tax
−Removed: December 11, 2020
−Removed: (Agostino Ricupati)
−Removed: (Principal Accounting Officer)
−Removed: /s/ COLLEEN E.
−Removed: December 11, 2020
−Removed: /s/ WILLIAM A.
−Removed: December 11, 2020
−Removed: December 11, 2020
−Removed: December 11, 2020
+Added: President, Chief Executive Officer and Director (Principal Executive Officer) December 10, 2021
/s/ ROBERT S.
−Removed: December 11, 2020
+Added: WEISS Chairman of the Board December 10, 2021
+Added: /s/ WILLIAM A.
+Added: KOZY Vice Chairman of the Board and Lead Director December 10, 2021
+Added: ANDREWS Executive Vice President, Chief Financial Officer & Treasurer December 10, 2021
+Added: Andrews) (Principal Financial Officer)
+Added: /s/ AGOSTINO RICUPATI Chief Accounting Officer & Senior Vice President, Finance & Tax December 10, 2021
+Added: (Agostino Ricupati) (Principal Accounting Officer)
+Added: /s/ COLLEEN E.
+Added: JAY Director December 10, 2021
+Added: LINDELL Director December 10, 2021
+Added: PETERSMEYER Director December 10, 2021
+Added: /s/ MARIA RIVAS M.D.
+Added: Director December 10, 2021
+Added: (Maria Rivas M.D.)
/s/ TERESA S.
−Removed: December 11, 2020
+Added: MADDEN Director December 10, 2021
THE COOPER COMPANIES, INC.
2 unchanged sentences
BOARD OF DIRECTORS
−Removed: Thomas Bender
Chairman of the Board
−Removed: Rubenstein, M.D.
Vice Chairman and Lead Director
−Removed: Chairman of the Board, CalAsia
−Removed: Pharmaceuticals, Inc.
President and Chief Executive Officer,
Management, Inc.
+Added: Maria Rivas M.D.
President & Chief Executive Officer
2 unchanged sentences
Lindell (Chairman)
+Added: Maria Rivas M.D.
Gary Petersmeyer
1 unchanged sentence
Kozy (Chairman)
−Removed: Rubenstein, M.D.
+Added: Maria Rivas M.D.
Organization and Compensation Committee
9 unchanged sentences
President of CooperSurgical, Inc.
−Removed: Auerbach, M.D
−Removed: Special Advisor to the Chief Executive Officer
McBride, Esq.
34 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.